AI ETF ARTY Soars 28% and Leaves QQQ in Dust Markets
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
Using Annuities And Stocks For Retirement Income
Using annuities and stocks for retirement income explains blending these assets to diversify risk and stabilize cash flow for retirement.
28,656 articles
Shaky Iran Ceasefire Tested as Drones Strike Ship Near Qatar
A drone strike lit a cargo ship off Qatar, testing a fragile Iran ceasefire. UAE and Kuwait reported drone incursions...
Investment Firm Buys $89.5: Belden Stock Move Examined
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
Ambarella's Sell Over 5,000 Shares: What It Signifies
When a company's CFO unloads thousands of shares, investors naturally ask what it means. This analysis dives into amb...
Becoming Chipmaker Just Revolutionized IBM’s Strategy
IBM unveils a groundbreaking 0.7nm nanostack in a research setting, reiterating it will not become a chipmaker. The m...
Prediction: Microsoft Stock Will Parabolic After July 29
A big earnings event could flip the script for Microsoft stock. This article breaks down why the bold idea of a parab...
Roboticist Cofounded Bankrupt Robot Warns About Humanoids
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
Oil Surges Over $100 as Markets Free Fall Worldwide
Global markets tumble as crude crosses the $100 mark, triggering a broad risk-off move and rising household costs. He...
BlackSky's Sold Over 15,000 Shares: What Investors Learn
When a company’s top executive sells stock, investors want to know why. This deep dive explains BlackSky's sold over ...
OpenAI’s Latest Model Likely Faces Security Flaws Now
UK AI Security Institute warns that openai’s latest model likely harbors jailbreak vulnerabilities that could enable ...
Dividend Kings Brink: Will These Two Lose Crowns in 2026
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status